Iofina plc (FRA:IF7)

Market Cap	74.10M +59.1%
Revenue (ttm)	49.09M +11.5%
Net Income	4.10M +33.5%
EPS	0.02 +39.4%
Shares Out	n/a
PE Ratio	18.06
Forward PE	15.86
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	889
Open	0.3600
Previous Close	0.3460
Day's Range	0.3600 - 0.3600
52-Week Range	0.2160 - 0.3860
Beta	n/a
RSI	59.75
Earnings Date	May 11, 2026

About Iofina

Iofina plc, together with its subsidiaries, explores for, develops, and produces iodine and halogen-based specialty chemical derivatives from oil and gas operations in North America, Asia, South America, Europe, and internationally. The company offers iodides, chlorides, and fluorides; and iodine used for animal care and health, biocides and catalysts, disinfectants, fungicide, specialty intermediates, mineral separators, thyroid health, wound healing, diagnostic imaging, iofina logo gray sun 5, preservatives and sanitizers, semiconductor etcha...

• Industry: Crude Petroleum and Natural Gas
• Founded: 2005
• Employees: 116
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: IF7

Financial Performance

In 2024, Iofina's revenue was $54.47 million, an increase of 8.85% compared to the previous year's $50.04 million. Earnings were $2.92 million, a decrease of -55.55%.

Financial numbers in USD